Michael S. Weiss

TG THERAPEUTICS

Chief Executive Officer and President

Overview

Michael S. Weiss received an average compensation of $8,250,210 at TG THERAPEUTICS from 2011 to 2017.

Annual data

2017

Non-Equity Incentive Plan$217,969
Salary$525,000
Stock Awards$9,183,647
Total$9,926,616

In 2017, Michael S. Weiss earned a total compensation of $9,926,616 as Chief Executive Officer and President at TG THERAPEUTICS, INC..

Weiss received $9,183,647 in stock awards, which accounts for 92.52% of total compensation.

Weiss also received $217,969 in non-equity incentive plan and $525,000 in salary.

Fortress Biotech

Executive Vice Chairman, Strategic Development

Overview

Michael S. Weiss received an average compensation of $5,277,307 at Fortress Biotech from 2014 to 2016.

Annual data

2016

Non-Equity Incentive Plan$500,000
Salary$29,689
Stock Awards$1,492,285
Other$72,015
Total$2,093,989

In 2016, Michael S. Weiss earned a total compensation of $2,093,989 as Executive Vice Chairman, Strategic Development at Fortress Biotech, Inc..

Weiss received $1,492,285 in stock awards, which accounts for 71.27% of total compensation.

Weiss also received $500,000 in non-equity incentive plan, $29,689 in salary and $72,015 in other compensation.

KERYX BIOPHARMACEUTICALS

Former Chairman and Chief Executive Officer

Overview

Michael S. Weiss received an average compensation of $4,302,891 at KERYX BIOPHARMACEUTICALS from 2006 to 2009.

Annual data

2009

Option Awards$263,585
Salary$273,085
Stock Awards$396,000
Other$666,705
Total$1,599,375

In 2009, Michael S. Weiss earned a total compensation of $1,599,375 as Former Chairman and Chief Executive Officer at KERYX BIOPHARMACEUTICALS INC.

Weiss received $666,705 in other compensation, which accounts for 41.69% of total compensation.

Weiss also received $263,585 in option awards, $273,085 in salary and $396,000 in stock awards.